In this study, the analysis of AML patient samples revealed that m6A RNA methyltransferases (METTL3, METTL4 and WTAP) and demethylases (FTO and ALKBH5) had significantly greater positive ratios in AML patients than in NCs (Figure 1A,B). The gene discussed is MBD2; the disease is acute myeloid leukemia.